Interim analysis of a phase 1 trial of SGN-CD33A in patients with CD33-positive acute myeloid leukemia (AML) Meeting Abstract


Authors: Stein, E. M.; Stein, A.; Walter, R. B.; Fathi, A. T.; Lancet, J. E.; Kovacsovics, T. J.; Advani, A. S.; DeAngelo, D. J.; O'Meara, M. M.; Zhao, B. T.; Kennedy, D. A.; Erba, H. P.
Abstract Title: Interim analysis of a phase 1 trial of SGN-CD33A in patients with CD33-positive acute myeloid leukemia (AML)
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349233805178
PROVIDER: wos
DOI: 10.1182/blood.V124.21.623.623
Notes: Meeting Abstract: 623 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eytan Moshe Stein
    342 Stein